Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 3
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Age-related differences in cancer biology in older patients.
Gammelgaard OL, Guldberg P, Gjerstorff MF, Ditzel HJ. Gammelgaard OL, et al. Ugeskr Laeger. 2024 Jan 22;186(4):V06230375. doi: 10.61409/V06230375. Ugeskr Laeger. 2024. PMID: 38305317 Free article. Review. Danish.
SSX addiction in melanoma propagates tumor growth and metastasis.
Traynor S, Ebstrup ML, Gammelgaard OL, Mansoori B, Terp MG, Rein CRH, Rattenborg S, Pedersen CB, Ditzel HJ, Gjerstorff MF. Traynor S, et al. Front Oncol. 2022 Oct 7;12:998000. doi: 10.3389/fonc.2022.998000. eCollection 2022. Front Oncol. 2022. PMID: 36276095 Free PMC article.
DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1.
Traynor S, Terp MG, Nielsen AY, Guldberg P, Jakobsen M, Pedersen PG, Gammelgaard OL, Pedersen CB, Pedersen MT, Rattenborg S, Ditzel HJ, Gjerstorff MF. Traynor S, et al. Cancer Lett. 2023 Jan 1;552:215982. doi: 10.1016/j.canlet.2022.215982. Epub 2022 Oct 27. Cancer Lett. 2023. PMID: 36309209 Free article.
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.
Alves CL, Ehmsen S, Terp MG, Portman N, Tuttolomondo M, Gammelgaard OL, Hundebøl MF, Kaminska K, Johansen LE, Bak M, Honeth G, Bosch A, Lim E, Ditzel HJ. Alves CL, et al. Among authors: gammelgaard ol. Nat Commun. 2021 Aug 25;12(1):5112. doi: 10.1038/s41467-021-25422-9. Nat Commun. 2021. PMID: 34433817 Free PMC article.
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.
Alves CL, Ehmsen S, Terp MG, Portman N, Tuttolomondo M, Gammelgaard OL, Hundebøl MF, Kaminska K, Johansen LE, Bak M, Honeth G, Bosch A, Lim E, Ditzel HJ. Alves CL, et al. Among authors: gammelgaard ol. Nat Commun. 2021 Sep 16;12(1):5588. doi: 10.1038/s41467-021-25901-z. Nat Commun. 2021. PMID: 34531405 Free PMC article. No abstract available.